Compound Detail
CHEMBL5428691
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5428691 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KAZWEGJIMJKIQL-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
444.5
MW (Da)
2.76
ALogP
7
HBA
1
HBD
96.5
PSA (Ų)
0.49
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.92
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SK-MEL-28 CHEMBL614919 | IC50 | 4.92 | 4.92 | 12160.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SK-MEL-28 | IC50 | = | 12160.0 | nM | 4.92 | Anticancer activity against human SK-MEL-28 cells assessed as inhibition in cell... | 37797804 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37797804 | 10.1016/j.bmcl.2023.129494 | HCT-116 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | B16-F10 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | A549 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | SK-MEL-28 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | MCF7 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | NRK-52E | 1 |
Data from ChEMBL 36 via Core Engine